Brief CV
Prof Philip LP Morris
Prof Morris has medical qualifications MBBS (Hons), BSc(med) (Hons), and PhD. He is qualified in psychiatry and addiction medicine in Australia and is a Fellow of the Royal Australian and New Zealand College of Psychiatrists (FRANZCP) and a Fellow of the Australasian Chapter of Addiction Medicine (FAChAM) of the Royal Australasian College of Physicians (RACP). He is qualified in general adult psychiatry and geriatric psychiatry in both Australia and the USA and is Board Certified by the American Board of Psychiatry and Neurology (AmBPN). Dr Morris is a member of the Faculty of Old Age Psychiatry and the Faculty of Forensic Psychiatry of the RANZCP. He is a Certified Independent Medical Examiner (CIME) with the American Board of Independent Medical Examiners (AmBIME). Prof Morris is a Distinguished Fellow and Board Director of the Pacific Rim College of Psychiatry.
Prof Morris is Executive Director of the Australian and New Zealand Mental Health Association. He is Medical Director of the Gold Coast Memory Disorders Clinic. He is immediate Past President of the Gold Coast Medical Association. He has a private psychiatric, psychogeriatric and medico-legal practice on the Gold Coast. He is a member of the Repatriation Pharmaceutical Reference Committee and is Principal Psychiatric Advisor to the Department of Veterans? Affairs. Dr Morris is Psychogeriatric Advisor to the Northern Territory Dementia Behaviour Management Advisory Service, and consultant psychogeriatrician for the Northern Territory Health Department.
Prof Morris is visiting Professor at the Faculty of Health Sciences and Medicine, Bond University, and visiting Professorial Fellow at the Centre for Forensic Excellence, Faculty of Law, Bond University. Prof Morris has held professor positions in psychiatry at the University of Melbourne and the University of Queensland, and at the School of Health Sciences at Bond University.
He has been Medical Superintendent of Macquarie Psychiatric Hospital, North Ryde NSW, and Director of Mental Health for the Gold Coast District Health Service. He was the Foundation Director of the Australian Centre for Post-traumatic Mental Health at the University of Melbourne. He was medical director of Mirikai, a drug and alcohol rehabilitation centre on the Gold Coast. He has been a member of the Queensland Compensation Commission (Q-Comp) Medical Assessment Tribunal ? Psychiatric, and was chairman of the RANZCP Continuing Professional Development Subcommittee.
His clinical and research interests include the psychiatric care of older adult patients, medical and surgical patients (consultation?liaison psychiatry), neuropsychiatry/psychogeriatrics, post-trauma syndromes, clinical drug trials, and co morbid drug and alcohol and psychiatric conditions. Dr Morris undertook post-graduate research and clinical training in the USA. He has published many scientific articles and reports and has won a number of competitive government research grants as well as pharmaceutical industry support for drug trials. He has conducted clinical drug trials in Australia since 1995. He is an external assessor for the Therapeutic Goods Administration.
Prof Morris has extensive experience in medico-legal assessment for a range of legal jurisdictions. Dr Morris is trained in the application of the American Medical Association Guides for the Assessment of Permanent Impairment, the Psychiatric Impairment Rating Scale (PIRS), the Comcare Permanent Impairment Guides, and the Guide to the Assessment of Rates of Veteran Pensions (GARP).
Prof Morris is available for clinical consultations and medico-legal reports. Contact him personally on 0422545753 or at pmorris@iprimus.com.au or at www.drphilipmorris.com. Appointments on the Gold Coast can be made at The Specialist Centre, Suite 2, Level 5, Pacific Private Clinic, 123 Nerang Street, Southport Qld 4215 (phone 07 55327655 and fax 07 55919183). Visit his website at www.drphilipmorris.com.
Curriculum Vitae
Philip Leo Patrick MORRIS
Mobile: 0422545753
email: pmorris@iprimus.com.au
Website: www.drphilipmorris.com
Present Positions
Private psychiatric practice, Gold Coast and Brisbane, Queensland.
Director, Gold Coast Memory Disorders Clinic.
Medico-legal practice, Queensland and NSW.
Director, Australian and New Zealand Mental Health Association.
Visiting Professor at the Faculty of Health Sciences and Medicine, Bond University.
Board Director and Distinguished Fellow, Pacific Rim College of Psychiatrists.
Immediate Past President, Gold Coast Medical Association.
Principal Psychiatric Advisor, Department of Veterans? Affairs.
Member, Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee.
Convener, Annual International Mental Health Conference Gold Coast.
Psycho-geriatric Advisor, Frontier Services Dementia Behaviour Management Advisory Service (DBMAS), Northern Territory.
Psycho-geriatric Advisor Northern Territory Health Department.
Psycho-geriatric Advisor, Dementia Behaviour Management Advisory Service (DBMAS), Alzheimer?s Australia Queensland Branch.
Academic Degrees
Bachelor of Science in Medicine (Honours) (BSc[Med]), University of New South Wales, Sydney, NSW, Australia 1972.
Bachelor of Medicine, Bachelor of Surgery (Honours) (MB BS), University of New South Wales, Sydney, NSW, Australia, 1975.
Doctor of Philosophy (Medicine) (PhD), University of Newcastle, Newcastle, NSW, Australia, 1990.
Specialty Qualifications
Certificate of Family Planning, Australian Family Planning Association, 1978.
Diploma of Obstetrics, Royal College of Obstetricians and Gynaecologists (D(Obs)RCOG), 1979.
Diplomat, Royal Australian College of Obstetricians and Gynaecologists (DRACOG), 1980.
Fellow, Royal Australian and New Zealand College of Psychiatrists (FRANZCP), 1985.
Board Certified (Diplomat), American Board of Psychiatry and Neurology (AmBPN), 1991.
Higher Qualification in Geriatric Psychiatry, American Board of Psychiatry and Neurology, 1994.
Fellow, Australasian Chapter of Addiction Medicine (FAChAM) of the Royal Australasian College of Physicians, 2002.
Certified Independent Medical Examiner (CIME), American Board of Independent Medical Examiners (ABIME), 2005, 2010 (Certificate No. 05-01566).
Medical Registration and Licenses
Medical Board of Australia # MED0001401884
Queensland, Australia, Medical Board # 970882
New South Wales, Australia, Medical Board # MPO 096604
Victoria, Australia, Medical Board # MPG 257568
HIC Provider # 0097826Y
HIC Prescriber # 334022
ECFMG Certificate # 2304095
FLEX ID # 490313016
Maryland, USA, Board of Physician Quality Assurance # D38703 (Specialist in Psychiatry)
Massachusetts, USA, Board of Physician Registration # 71282/998795
US Drug Enforcement Agency, Controlled Substances Registration # BM1908574
Maryland Controlled Dangerous Substances Registration # M30431
General Medical Council (UK) # 2659602
Previous Positions
Board Director, Australian Medical Association Queensland Branch, 2010-2012.
Gold Coast Region Representative for Australian Medical Association Queensland Branch, 2009-2012.
Chairman, Continuing Professional Development Subcommittee, RANZCP, 2005-2007.
Member, Q-COMP Medical Assessment Tribunal ? Psychiatric, 2000-2006.
Medical Director, Mirikai Drug and Alcohol Rehabilitation Centre, West Burleigh, Queensland 2003-2008.
Medical Superintendent and Director of Medical Services, Macquarie Hospital, North Ryde, NSW, 2004-2005.
Professor, Department of Psychiatry, University of Queensland, 1997-2003.
Director of Mental Health and Director of Psychiatry, Gold Coast Integrated Mental Health Service, 1997-2002.
Adjunct Professor of Health Sciences, Bond University, 2000-2002.
Foundation Director, Australian Centre for Post Traumatic Mental Health, Austin and Repatriation Medical Centre, Heidelberg, Victoria, 1994-97.
Professor, Department of Psychiatry, University of Melbourne, Victoria, 1995-97.
Associate Professor, Department of Psychiatry, University of Melbourne, Victoria, 1992-95.
Chairman, Research Committee, Department of Psychiatry, University of Melbourne, Victoria, 1994-97.
Consultant Psychiatrist, Victoria Police Medical Centre, Melbourne, Victoria, 1993-97.
Director, Department of Psychiatry, Heidelberg Repatriation Hospital, Victoria, 1993-95.
Chairman, Continuing Education Committee, NSW Branch RANZCP, NSW, 1983-87.
Director, Consultation-Liaison Psychiatry, Royal Newcastle Hospital, NSW, 1983-87.
Residency Training
Post Graduate General Medical Residency in Australia
Medical and Surgical Intern, Sydney Hospital, Sydney, Australia, 1975.
Medical Resident, Sydney Hospital, Sydney, Australia, 1976.
Community Medicine Resident, School of Community Medicine, University of NSW, Sydney, Australia, January to April 1977.
Anaesthetic Resident, Prince of Wales Hospital, Sydney, Australia, April to July 1977.
Obstetric Resident, St Margaret?s Hospital, Sydney, Australia, July to December 1977.
Post Graduate Psychiatric Training in Australia
Psychiatric Registrar, St. George Hospital, Sydney, Australia, 1978. Six months Adult Inpatient Psychiatry, six months Adult Outpatient Psychiatry.
Psychiatric Registrar, Royal Prince Alfred Hospital, Sydney, Australia, 1979, 80, 81. Six months Child and Adolescent Psychiatry, six months Adult Consultation-Liaison Psychiatry, six months Adult Rehabilitation Psychiatry, 18 months Adult Inpatient Psychiatry.
Senior Psychiatric Registrar (Fellow), Royal Newcastle Hospital, Newcastle, Australia, 1982. Six months Adult Inpatient Psychiatry, six months Adult Outpatient Psychiatry.
Post Graduate Psychiatric Training in USA
Psychiatric Resident (Fellow in Consultation-Liaison Psychiatry, Rhode Island Hospital), Psychiatric Residency Program, Brown University, Providence RI, 1987-89.
Post-doctoral Research Associate, Department of Psychiatry, The Johns Hopkins School of Medicine, Baltimore Md, 1989-90.
Post-doctoral Research Associate, Maryland Psychiatric Research Centre, University of Maryland School of Medicine, Baltimore Md, 1991-92.
Scientific Peer Review
Grant reviewer, Australian National Health and Medical Research Committee, 1986 ? current.
Grant reviewer, Australian Institute of Health, 1987 ? current.
Grant reviewer, Sandoz Foundation for Gerontology Research, Regional Committee for Australia, New Zealand, Asia and Africa, 1988.
Grant reviewer, Australian National Occupational Health and Safety Commission, 1988 ? current.
Publication reviewer, Psychosomatics, 1988 ? current.
Publication reviewer, International Journal of Psychiatry in Medicine, 1990 ? current.
Publication reviewer, General Hospital Psychiatry, 1990 ? current.
Publication reviewer, Southern Medical Journal, 1994 ? 2000.
Publication reviewer, Journal of Neuropsychiatry and Clinical Neuroscience, 1995 ? current.
Publication reviewer, Australian and New Zealand Journal of Psychiatry, 1995 ? current.
Publication reviewer, Medical Journal of Australia, 1995 ? current.
Publication reviewer, Journal of Traumatic Stress, 1995 ? current.
Publication reviewer, Australian Drug and Alcohol Review, 2002 ? current.
Research Project Grants
Australian National Health and Medical Research Council. Undergraduate Research Scholarship, 1971 ($5,000).
World Health Organisation (Manila, Philippines). Funding for the International Interdisciplinary Educational Workshop for Students from the Health Professions (Workshop Director), 1974 ($3,000).
NSW Institute of Psychiatry, Sydney, Australia. Research Fellowship, 1985 ($18,000).
Australian Institute of Health, Commonwealth of Australia. Research and Development Grant for Post-Stroke Depressive Disorder (Principle Investigator), 1987 ($10,000).
US National Institute of Mental Health Grant No. MH40355. Mood Disorders in Stroke Patients (Associate Investigator), 1986-1991 (US$635,348).
University of Melbourne. A Neuroanatomical and Neurotransmitter Study of Post-stroke Depression (Principal Investigator), 1993-94 ($8,000).
National Health and Medical Research Council. A Neuroanatomical and Neurotransmitter Study of Post-stroke Depression (Principal Investigator), 1994-96 ($63,000).
Central Health and Medical Research Committee (DVA). A Neuroanatomical and Neurotransmitter Study of Post-stroke Depression (Principal Investigator), 1994-96 ($21,000).
Central Health and Medical Research Committee (DVA). A Neurotransmitter Study of Chronic Post-traumatic Stress Disorder (Principal Investigator), 1994-96 ($63,000).
Central Health and Medical Research Committee (DVA). Psychological Treatment of Combat Related Post-traumatic Stress Disorder (Co-principal Investigator), 1994 ($15,000).
Dunlop Foundation. A Neurotransmitter Study of Chronic Post-traumatic Stress Disorder (Principal Investigator), 1994 ($6,000).
Dunlop Foundation. A Neuroanatomical and Neurotransmitter Study of Post-stroke Depression (Principal Investigator), 1994 ($6,000).
Dunlop Foundation. Naltrexone in the Treatment of Alcohol Dependence (Principal Investigator), 1995 ($8,000).
Central Health and Medical Research Committee (DVA). Naltrexone in the Treatment of Alcohol Dependence (Principal Investigator), 1995-97 ($165,000).
National Health and Medical Research Council (DVA funded section). An ERP and PET activation study of PTSD (Co-principal Investigator), 1996-97 ($100,000).
Smith Klein Beecham. Platelet paroxetine binding in PTSD (Co-principal Investigator), 1995-96 ($10,000).
Wyeth Pharmaceuticals. Venlafaxine treatment of PTSD (Co-principle Investigator), 1997 ($52,000).
National Health and Medical Research Council (DVA funded section). A PET study of benzodiazepine receptors in PTSD and Panic Disorder (Principal Investigator), 1998-2000 ($240,000).
National Health and Medical Research Council. Partnerships Grant: Evaluation of an Integrated Strategy to Promote the Health of People with Chronic or Recurring Mental Disorders (Associate Investigator), 2003-07 ($2,500,000).
Pharmaceutical Industry Sponsored Clinical Drug Trials
Eli Lilly. IM Olanzapine for acute agitation in Schizophrenia (Principal Investigator), 19998-2000 ($100,000).
Eli Lilly. Olanzapine for acute and maintaince therapy of Bipolar Disorder (Principal Investigator), 1999-2001 ($50,000).
Pfizer. Sertraline for the acute treatment of Generalized Anxiety Disorder (Principal Investigator), 2000-02 ($150,000).
Eli Lilly. Duloxetine for melancholic depression trial (Associate Principle Investigator), 2005.
Astra Zeneca. Quetiapine for PTSD (Principal Investigator), 2005-2006 ($30,000)
Takeda. Trial of new antidepressant for major depression (Principal Investigator) 2009.
Servier. Trial of new anti-Alzheimer?s drug for dementia (Principal Investigator) 2009-2012.
Clinical and Centre Project Grants
The National Centre for War Related Post-Traumatic Stress Disorder. Commonwealth Department of Veterans? Affairs (DVA), 1994-2000 ($3,000,000).
Heidelberg Repatriation Hospital PTSD Clinical Program. Commonwealth Department of Veterans? Affairs (DVA), 1994-98 ($2,500,000).
Published Work
Morris PLP: An International Interdisciplinary Educational Workshop for Students from the Health Professions. Medical Journal of Australia 136: 515-516, 1975.
Morris PLP: Depression following Brain Injury. Proceedings of the 8th Brain Impairment Conference, October, University of Newcastle, Australia, 1983.
Morris PLP: Phenomenology of Secondary Depression (abstract). Proceedings of the Australian Society for Psychiatric Research Annual Conference, University of Melbourne, Australia, 1983.
Morris PLP: Psychiatric Sequel in Living Related Kidney Donors (abstract). Proceedings of the Australian Society for Psychiatric Research Annual Conference, University of NSW, Australia, 1984.
Morris PLP: Psychiatric complications in living related kidney donors (abstract). Proceedings of the Consultation Liaison Psychiatry Conference, Continuing Education Committee RANZCP (NSW), Australia, 1985.
Morris PLP: Psychosocial sequel in living related kidney donors (abstract). Proceedings of the Australian Transplantation Society Annual Conference, Australian National University, April 1986.
Morris PLP: Impotence ?Down Under? (letter). Impotence ?86 (Journal of Impotents Anonymous, Maryville, TN), September 1986.
Morris PLP: Training Family Physicians in Psychiatry (letter). ?News and Notes?, RANZCP, October 1986.
Morris PLP: Foreword in: The Clinical use of Clonazepam in Psychiatry. G Chouinard. Excerpta Medica Monograph, 1986.
Morris PLP: Transplantation versus Dialysis: A Study of Quality of Life (abstract). Proceedings of the Australian Transplantation Society Annual Conference, University of Adelaide, Australia, 1987.
Morris PLP, St George B, Waring T, Nanra R: Psychosocial Complications in Living Related Kidney Donors. Transplantation Proceedings 19: 2840-2845, 1987.
Morris PLP: The Rational Use of Benzodiazepines. Panakea 1(3), 1987.
Morris PLP, Raphael B: Depression Associated with Physical Illness: The Impact of Stroke. General Hospital Psychiatry 9: 324-330, 1987.
Morris PLP, Jones B: Transplantation versus Dialysis: A Study of Quality of Life. Transplantation Proceedings 20: 23-26, 1988.
Morris PLP: Stress and Coronary Heart Disease (letter). Australian and New Zealand Journal of Psychiatry 22:135, 1988.
Morris PLP: A Note of Caution Concerning Living Related Kidney Donation (letter). Medical Journal of Australia 147:396, 1988.
Morris PLP: The Rational Use of Antidepressants. Panakea 2, 1988.
Goldberg RJ, Morris PLP, Christian F et al: Panic Disorder Prevalence in Cardiology Patients (abstract). Proceedings of the American Psychiatric Association 142nd Annual Meeting, San Francisco, CA, 1989.
Morris PLP, Jones B: Life Satisfaction and Psychological Adjustment to Treatment Methods For End Stage Renal Disease. Medical Journal of Australia 150: 428-431, 1989.
Morris PLP, Goldberg R: The Validity of the 28 Item General Health Questionnaire in Gastroenterology Inpatients. Psychosomatics 30: 290-295, 1989.
Badger J, Morris PLP: Observations of a Group Support Program for Patients with the Automatic Implantable Cardioverter-Defibrillator (AICD). Heart and Lung 18: 238-242, 1989.
Edlund MJ, Conrad C, Morris PLP: Accidents Among Schizophrenic Outpatients. Comprehensive Psychiatry 30: 522-526, 1989.
Morris PLP, Goldberg RJ: The Impact of Psychiatric Comorbidity on Length of Hospital Stay in Gastroenterology Patients. General Hospital Psychiatry 12: 77-82, 1990.
Morris PLP, Whyte I, Mearrick P: Plasma concentration of mianserin hydrochloride in depressed medically ill patients (letter). Australian and New Zealand Journal of Psychiatry 24: 11-12, 1990.
Goldberg RJ, Morris PLP, Christian F et al: Panic Disorder in Cardiology Outpatients. Psychosomatics 31: 168-173, 1990.
Goldberg RJ, Morris PLP, Lidofsky S: Tardive Dyskinesia Presenting as GI Disorder. Journal of Clinical Psychiatry 51: 253-254, 1990.
Robinson RG, Morris PLP, Fedoroff JP: Depression and cerebrovascular disease. Journal of Clinical Psychiatry 51(suppl): 26-31, 1990.
Morris PLP, Robinson RG, Raphael B: Prevalence and course of post-stroke depression in hospitalized patients. International Journal of Psychiatry in Medicine 20: 327-342, 1990.
Morris PLP, Badger J, Chimielewski C, Berger E, Goldberg RJ: Psychiatric morbidity following implantation of the Automatic Implantable Cardioverter-Defibrillator. Psychosomatics 32: 58-64, 1991.
Morris PLP, Badger J, Chimielewski C, Berger E, Goldberg RJ: Psychiatric morbidity following implantation of the Automatic Implantable Cardioverter-Defibrillator (abstract). Psychiatry Digest 7: 27, 1991.
Mayberg H, Parikh R, Morris PLP, Robinson RG: Spontaneous remission of post-stroke depression and temporal changes in cortical serotonin S2 receptors measured by positron emission tomography. Journal of Neuropsychiatry and Clinical Neuroscience 3: 80-83, 1991.
Morris PLP, Robinson RG, Raphael B, Bishop D: The relationship of gender and social support to post-stroke depression. Psychiatry: Interpersonal and Biological Processes 54: 306-316, 1991.
Mayberg HS, Starkstein SE, Morris PLP et al: Remote cortical hypometabolism following focal basal ganglia injury: relationship to secondary changes in mood (abstract). Proceedings of the American Association of Neurology 41: 266, 1991.
Edlund MJ, Goldberg RJ, Morris PLP: The use of physical restraint in patients with cerebral contusion. International Journal of Psychiatry in Medicine 21: 173-182, 1991.
Morris PLP: Cerebral glucose metabolism measured by PET in major depression (letter). American Journal of Psychiatry 148: 1103, 1991.
Morris PLP: Psychiatric co-morbidity and hospital length of stay (letter). American Journal of Psychiatry 148: 1623-1624, 1991.
Morris PLP: Fluoxetine and sexual sensations. International Journal of Psychiatry in Medicine 21: 379-382, 1991.
Morris PLP: Post stroke depression and general hospital psychiatry (letter). Australian and New Zealand Journal of Psychiatry 25: 445-446, 1991.
Morris PLP, Robinson RG, Raphael B: Lesion characteristics and post-stroke depression: Evidence of a specific relationship in the left hemisphere. Journal of Neuropsychiatry, Neuropsychology and Behavioral Neurology 3: 75-82, 1992.
Morris PLP, Robinson RG, Raphael B, Molloy P, Samuels J: Risk factors for affective disorder predict post stroke depression. Australian and New Zealand Journal of Psychiatry 26: 208-217, 1992.
Morris PLP, Raphael B, Robinson RG: Clinical depression is associated with poor recovery from stroke. Medical Journal of Australia 157: 239-242, 1992.
Morris PLP, Robinson RG: Depression, social support and mortality (letter). Journal of the American Medical Association 268: 196, 1992.
Morris PLP: The future of psychiatry (letter). Australian and New Zealand Journal of Psychiatry 26: 322-323, 1992.
Morris PLP: Consultation-liaison psychiatry intervention and length of hospital stay in hip fracture patients (letter). American Journal of Psychiatry 149: 1414, 1992.
Morris PLP: Retiring ?Organic Mental Disorders? (letter). American Journal of Psychiatry 149: 1618, 1992.
Morris PLP, Robinson RG, Andrzejewski P, Samuels J, Price TR: Clinical depression is associated with 10-year post stroke mortality. American Journal of Psychiatry 150: 124-129, 1993.
Morris PLP, Robinson RG: Psychiatric consequences of stroke, including post stroke depression (chapter), in; Adams HP (editor) Handbook of Cerebrovascular Diseases. New York, Marcel Dekker Inc. 1993.
Morris PLP, Robinson RG, Samuels J: Depression, introversion and mortality following stroke. Australian and New Zealand Journal of Psychiatry 27: 443-449, 1993.
Morris PLP, Robinson R G, Raphael B: Emotional lability after stroke. Australian and New Zealand Journal of Psychiatry 27: 601-605, 1993.
Morris PLP, Mayberg HS, Bolla K, Wong D, Starkstein SE, Robinson RG: A preliminary study of cortical serotonin receptor function and cognitive performance following stroke. Journal of Neuropsychiatry and Clinical Neuroscience 5 (4): 395-400, 1993.
Morris PLP, Shields R, Hopwood M, Robinson RG, Raphael B: Are there two depressive syndromes following stroke? Journal of Nervous and Mental Disease 182: 230-234, 1994.
Hopwood M, Morris PLP: Drug treatment of Alzheimer?s disease. Australian Journal of Hospital Pharmacy 24: 701-704, 1994.
Hopwood M, Morris PLP: Focus on Fluoxetine. Veterans? Health 55: 21-22, 1994.
Morris PLP, Robinson RG: Personality neuroticism and depression following stroke. International Journal of Psychiatry in Medicine 25: 93-102, 1995.
Morris PLP, Hopwood M, Norman T, McFarlane A: Post traumatic stress disorder. Proceedings of Anxiety Disorders in the 90?s, Obsessive Compulsive Disorder Foundation of Victoria, Grand Hyatt, Melbourne, Victoria, 1995.
Morris PLP, Hopwood M, Norman T, McFarlane A: Does your veteran suffer from post traumatic stress disorder? Veterans? Health 56, 1995.
Morris PLP, Bonwick R: WWII veterans: Is post traumatic stress disorder a problem? Veterans? Health 56, 1995.
Morris PLP, Hopwood M, Norman T, Schweitzer I: Noradrenergic and serotonergic alterations in PTSD (abstract). Proceedings of the CINP Congress, Melbourne, Victoria, June 1996.
Chua P, Egan G, Morris PLP, Burrows G: A PET study of cerebral blood flow activation during a cognitive task in major depression (abstract). Proceedings of the CINP Congress, Melbourne, Victoria, June 1996.
Morris PLP, Robinson RG, Carvalho ML, Albert P, Wells JC, Samuels JF, Eden-Fetzer D, Price TR: Lesion characteristics and depressed mood in the Stroke Data Bank study. Journal of Neuropsychiatry and Clinical Neuroscience 8: 153-159, 1996.
Bonwick R, Hopwood M, Morris PLP: Neuroleptic malignant syndrome and Resperidone: A case report. Australian and New Zealand Journal of Psychiatry 30: 419-421, 1996.
Morris PLP, Robinson RG, Raphael B, Hopwood M: Lesion location and post-stroke depression. Journal of Neuropsychiatry and Clinical Neuroscience 8: 339-403, 1996.
Bonwick R, Morris PLP. PTSD among elderly veterans. International Journal of Geriatric Psychiatry 11: 1071-1076, 1996.
Morris PLP, Hopwood M, Marcina J, Norman T, Schweitzer I. Central noradrenergic and serotonergic neurotransmitter function in chronic PTSD. European Neuropsychopharmacology 6: 81, 1996.
Burrows GD, Egan GF, Ellen SR, McKay WJ, Morris PLP, Norman T, O?Sullivan BT, Tochon-Danguy. 11C-flumazenil PET studies in panic disorder patients pre- and post-treatment (abstract). Proceedings of Second Australian Symposium on Brain Imaging, Newcastle, NSW, 1997.
Clark CR, Egan GF, McFarlane A, Morris PLP, Weber DL, Becker P, Soda J, Ellen SR, McKay WJ, Tochon-Danguy HJ. PET ERP correlational studies of cognitive deficites in PTSD patients (abstract). Proceedings of Second Australian Symposium on Brain Imaging, Newcastle, NSW, 1997.
Morris PLP: The role of medications in chronic PTSD (abstract). Australian and New Zealand Journal of Psychiatry 31 (supplement 1): A13, 1997.
Morris PLP: Managed Care-A Personal View. Australasian Psychiatry 5: 127-8, 1997.
Creamer M, Morris PLP. Treatment outcome in Australian veterans with chronic PTSD: Preliminary findings (abstract). Proceedings of ISTSS Annual Meeting XIII, Montreal, Canada, 1997.
Maguire K, Norman T, Burrows GD, Hopwood M, Morris PLP. Platelet paroxetine binding in PTSD. Psychiatry Research 77: 1-7, 1998.
Lyketsos CG, Triesman GJ, Lipsey JR, Morris PLP, Robinson RG. Does stroke cause depression? Journal of Neuropsychiatry and Clinical Neuroscience 10: 103-7, 1998.
Clark CR, Egan GF, McFarlane AC, Morris P, Weber DL, Sonkkilla C, Soda J. A high resolution ERP and PET investigation of verbal working memory. Brain Topography, 11: 80-81, 1998.
Morris PLP: General hospital psychiatry (letter). Australasian Psychiatry 7: 36-37, 1999.
Clark RC, Egan GF, McFarlane AC, Morris PLP, Weber D, Sonkkilla C, Marcina J, Tochon-Danguy HJ. Updating working memory for words: a PET activation study. Human Brain Mapping 9(2), 1999.
Morris PLP, Raphael B, Bordujenko A (editors). Stress and Challenge: Health and Disease (monograph). Brisbane, Repatriation Medical Authority 1999.
Raphael B, Morris PLP, Bordujenko A. Executive Summary and Conference Overview. Chapter in Raphael B, Morris PLP, Bordujenko A (eds), Stress and Challenge: Health and Disease. Brisbane, Repatriation Medical Authority 1999.
Creamer M, Morris PLP, Biddle D, Elliott P. Treatment outcome in Australian Veterans with combat-related posttraumatic stress disorder: A cause for cautious optimism? Journal of Traumatic Stress 12 (4):545-558, 1999.
Clark CR, Moores KA, Lewis A, Fitzgibbon S, Orr R, Weber DL, Taylor J, Brown G, Egan G, Morris PLP, McFarlane AC, Puce A. Investigations of human working memory function using multimodal imaging. International Journal of Psychophysiology 35: 13-14, 2000.
Weber DL, Clark CR, McFarlane AC, Morris PLP, Marcina J. Abnormal stimulis evaluation in post-traumatic stress disorder. Brain Topography 12: 303-319, 2000.
Clark CR, Egan GF, McFarlane AC, Morris PLP, Weber D, Sonkkilla C, Marcina J, Tochon-Danguy HJ. Updating working memory for words: a PET activation study. Human Brain Mapping 9(1): 42-54, 2000.
Clark CR, McFarlane AC, Morris PLP, Egan GF, Weber DL, Sonkkilla C, Marcina J, Tochon-Danguy HJ. Neurobiological evidence of everyday working memory dysfunction in PTSD using PET and high density EEG (abstract). Australian and New Zealand Journal of Psychiatry 34 (suppl), A13, 2000.
Ellen SR, Morris PLP, Olver JS, Reutens D, Norman TR, Touchon-Danguy HJ, Constant E, Ignatiadis S, McFarlane AC, Egan GF, Burrows GD. A PET study of benzodiazepine receptors in PTSD (abstract). Australian and New Zealand Journal of Psychiatry 34 (suppl), A21, 2000.
Hopwood M, Morris PLP, Debenham P, Bonwick R, Parkin I, Ignatiadis S, Norman T, Burrows GD. An open label trial of Venlafaxine in war veterans with chronic PTSD (abstract). Australian and New Zealand Journal of Psychiatry 34 (suppl), A31, 2000.
Morris PLP. Is consensus about debriefing possible? Chapter in Raphael B, Wilson JP (eds), Psychological Debriefing. Cambridge University Press, Cambridge, UK, 2000.
Morris PLP, Rushton P. Depression and post-traumatic stress disorder. Mental Health Australia 2 (2):16-21, 2000.
Weber DL, Clark CR, McFarlane AC, Morris PLP, Marcina J. Neural stimulus processing in post-traumatic stress disorder. International Journal of Psychophysiology 35:59. 2000.
Morris PLP, Hopwood M, Whelan G, Gardiner J, Drummond E. Naltrexone for alcohol dependence. Addiction 96:1565-1573, 2001.
Clark CR, McFarlane AC, Morris PLP, Weber DL, Sonkkilla C, Marcina J, Tochon-Danguy HJ, Egan GF. Cortical network dysfunction in post-traumatic stress disorder. Neuroimage 13: S1038, 2001.
Morris PLP. Continuum of care models in the private sector. Proceedings of the National Forum 2001. Canberra, Strategic Planning Group for Private Psychiatric Services 2001.
Morris PLP, Rushton P. Post traumatic psychiatric illness. Veterans? Health 62, December, 2001.
Shaw ME, Strother AC, McFarlane AC, Morris PLP, Anderson J, Clark CR, Egan GF. Abnormal functional connectivity in post-traumatic stress disorder. Neuroimage 15: 661-74, 2002.
Clark CR, McFarlane AC, Morris PLP, Weber D, Sonkkilla J, Marcina J, Tochon-Danguy HJ, Egan GF. Investigating the generators of the scalp P300 using cortically constrained source localisation. Neuroimage 15: S1038, 2002.
Rushton P, Morris PLP. Panic Disorders and Cardiovascular Disease. Chapter in Chiu E (Ed), Vascular Disease and Affective Disorders. Martin Dunitz, London, UK, 2002.
Petchkovsky L, Morris PLP, Rushton P. Choosing a psychodynamic psychotherapy model for an Australian public sector mental health service. Australasian Psychiatry 10 (4):330-333, 2002.
De Leo D, Swanton K, Harper C, Firman D, Leorin C, Burgess S, Morris PLP, Pollard G. The Gold Coast Suicide Prevention Community Study: Interim Report (abstract). Australian and New Zealand Journal of Psychiatry 36 (suppl), A6-7, 2002.
Morris PLP. Naltrexone treatment of alcohol dependence in psychiatrically ill patients (abstract). Australian and New Zealand Journal of Psychiatry 36 (suppl), A29-30, 2002.
Morris PLP. Psychotherapy in a public mental health service (abstract). Australian and New Zealand Journal of Psychiatry 36 (suppl), A29, 2002.
Weber DL, Clark CR, McFarlane AC, Morris PLP, Egan G. Abnormal stimulus evaluation in post-traumatic stress disorder. Australian Journal of Psychology 55:S29, 2002.
Weber DL, Clark CR, McFarlane AC, Morris PLP, Egan G. Selective attention and stimulus evaluation in post-traumatic stress disorder. Neuroimage 19:638, 2003.
Wright P, Meehan K, Birkett M, Lindborg S, Taylor C, Morris PLP, Brier A. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy. Clinical Therapeutics 25:1420-1428, 2003.
Morris PLP, Maguire K, Schweitzer I, Norman T, Hopwood M. Blunted prolactin response to d-Fenfluramine in post-stroke major depression. Journal of Affective Disorders 76:273-278, 2003.
Clark CR, McFarlane AC, Morris PLP, Weber DL, Sonkkilla C, Shaw M, Marcina J, Tochon-Danguy HJ, Egan GF. Cerebral function in posttraumatic stress disorder during verbal working memory updating: a positron emission tomography study. Biological Psychiatry 53:474-481, 2003.
Morris PLP, Dahl AA, Kutcher SP, Sogaard JA, Allgulander C, Burt T. Efficacy of sertraline for the acute treatment of generalized anxiety disorder (GAD). European Neuropsychopharmacology 13 (suppl 4):S375, 2003.
Morris PLP. Clinical practice guidelines (letter). Australasian Psychiatry 11:345, 2003.
Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PLP, Breier A. Intramuscular Olanzapine and intramuscular haloperidol in acute schizophrenia: Antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Canadian Journal of Psychiatry 48:689-694, 2003.
Weber DL, Clark CR, McFarlane AC, Morris PLP, Egan G. Event related potentials indicate deficient working memory in post-traumatic stress disorder. Clinical EEG and Neuroscience 35:238-239, 2004.
Morris PLP, Hopwood M, Maguire K, Schweitzer I, Norman T, Marcina J. Blunted Growth Hormone Response to Clonidine in PTSD. Psychoneuroendocrinology 29:269-278, 2004.
Morris PLP, Lloyd C. Vocational rehabilitation in psychiatry-a re-evaluation. Australian and New Zealand Journal of Psychiatry 38:490-494, 2004.
Allgulander C, Dahl AA, Kutcher SP, Morris PLP, Sogaard JA, Fayyad R, Clary CM, Austin C. Efficacy of sertraline for the acute treatment of generalised anxiety disorder. American Journal of Psychiatry 161:1642-9, 2004.
Schweitzer I, Morris PLP, Hopwood M, Maguire K, Norman T. Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorder. International Journal Neuropsychopharmacology 7:291-8, 2004.
Morris PLP. Recent Advances in Psychiatry. The Medical Link, Issue 37 Oct/Nov 2004.
Weber DL, Clark CR, McFarlane AC, Moores KA, Morris PLP, Egan G. Abnormal frontal and parietal working memory updating in post-traumatic stress disorder. Psychiatry Research 40:27-44, 2005.
Morris PLP. Natural medicines for alcoholism treatment (editorial). Drug and Alcohol Review 24 (6):473, 2005.
Morris PLP, Lloyd C. Vocational rehabilitation in psychiatry: what works best? (abstract) Australian and New Zealand Journal of Psychiatry 39 Suppl: A87, 2005
Ellen s, Morris P, Olver J, Norman T, McFarlane A, Reutens D, Tochon-Danguy, Burrows G. Benzodiazepine receptors abnormalities in anxiety disorders: a positron emission tomography study (abstract). Australian and New Zealand Journal of Psychiatry 39 Suppl: A149-150, 2005.
Morris PLP. Dual Action in Depression. The Medical Link, Issue 40 Apr/May 2005.
Morris PLP. Doctor Profile: Dr Philip Morris. The Medical Link, Issue 42 Aug/Sept 2005.
Morris PLP. ?GP Psych Opinion?: evaluation of a psychiatric consultation service (letter). Medical Journal of Australia 184:139, 2006.
Morris PLP. The Australian mental health crisis: a system failure in need of treatment. Australasian Psychiatry 14:332-333, 2006.
Morris PLP. Invasive physical treatments in psychiatry. Pacific Rim College of Psychiatrists Newsletter, August 2006.
Morris PLP. Mental Health Crisis. The Medical Link, Issue 45 Feb/Mar 2006.
Morris PLP. Invasive Physical Treatments in Psychiatry. The Medical Link, Issue 49, Oct/Nov 2006.
Morris PLP. A Looming Crisis in Psychiatric Training. The Medical Link, Issue 47 Jun/July 2006.
Morris P. The Australian Mental Health Crisis: A system failure in need of treatment. Australian and New Zealand Journal of Psychiatry 41 Suppl 1:A64, 2007.
Morris P. The Revised College Continuing Professional Development Program Update. Australian and New Zealand Journal of Psychiatry 41 Suppl 1:A64, 2007.
Petchkovsky L, Petchkovsky M, Montgomery D, Dwyer J, Morris P, Burnett P. A pilot study: investigating the functional magnetic resonance imaging correlates of ?complexed? responses to Jung?s word association test. Australian and New Zealand Journal of Psychiatry 41 Suppl 1:A70, 2007.
Morris PLP. The Australian mental health crisis: a system failure in need of treatment. On Line Opinion, October 2, 2007.
Robertson M, Rushton P, Batrim D, Moore E, Morris PLP. An open trial of interpersonal psychotherapy for chronic post traumatic stress disorder. Australasian Psychiatry 15:375-379, 2007.
Morris PLP. APEC meeting in Australia. Pacific Rim College of Psychiatrists Bulletin, December 2007, pg 3.
Morris PLP. Memory Complaints are a common problem. The Medical Link, Dec/Jan Issue 50, 2007.
Morris PLP, Lancaster J. The continuous professional development program of the RANZCP (letter). Australasian Psychiatry, September 2009.
Morris PLP. Predicting who will get dementia. The Medical Link, Issue 71 July/Aug 2010.
Morris PLP. ?Am I losing my marbles Doc?? The Medical Link, Issue 73 Nov/Dec 2010.
Morris PLP. The assessment and treatment of dementia. WebmedCentral Psychiatry 2010;1(9):WMC00843.
Morris PLP. Conference report ? Pacific Rim College of Psychiatrists 14th Scientific Meeting 28-30 Oct 2010, Brisbane, Queensland, Australia. Asia-Pacific Psychiatry 2 (4):219-220, 2010.
Morris PLP. Senior Active Doctors Category. The Medical Link, Issue 79 Nov/Dec 2011.
Morris PLP. Inquiry into involuntary Detoxification in Queensland. The Medical Link, Issue 80 Feb/Mar 2012.
Morris PLP. Public Disclosure of payments to Doctors from Drug companies. The Medical Link, Issue 81 Apr/May 2012.
Morris PLP. Dementia ? A Chronic Disease Management Approach?. The Medical Link, Issue 83 Aug/Sept 2012.
Morris P. New mental health acts in Australia and their effect on psychiatric care. Asia-Pacific Psychiatry 4 (suppl 1): 10, 2012.
Submitted Work
Webber DL, Clark CR, McFarlane AC, Morris PLP, Egan G. Event-related potential indices of selective attention in post-traumatic stress disorder.
Hopwood MJ, Ignatiadis S, Morris PLP, Debenham P, Bonwick R, Norman TR, Burrows GD. An open label trial of venlafaxine in chronic post traumatic stress disorder.
Hopwood MJ, Morris PLP, Maguire K, Norman TR, Schweitzer I. A study of the low dose dexamethasone suppression test in combat-related post traumatic stress disorder.
Samra P, Kirkwood E, Morris PLP. Directions for occupational therapy in a post-traumatic stress disorder programme for Vietnam veterans.
Dissertations/Theses
Bachelor of Science (Medicine), University of N.S.W, 1972. Thesis title: ?Childhood Dyslexia: its prevalence in a school population?.
RANZCP, Dissertation for College Membership, 1983. Dissertation title: ?Growth hormone response to clonidine infusion in depressed psychiatric patients?.
Doctoral Thesis (Medicine), University of Newcastle, N.S.W, 1989. Thesis title: ?The Prevalence, Course and Selected Correlates of Post-stroke Depression?.
Reports
PLP Morris. Debriefing Report: Psychiatric Consultant RAAF 3 Hospital, Butterworth, Malaysia, 1985.
PLP Morris. The Accreditation of Continuing Education Programmes in Psychiatry. Report for the RANZCP, 1986.
PLP Morris. Planning the provision of General Hospital Psychiatric Units and Consultation-Liaison Psychiatry Services in the Hunter Region. Report for the NSW Department of Health, 1986.
PLP Morris. Consultation-Liaison Services in the Hunter Region General Hospitals. Report for the NSW Department of Health, 1987.
PLP Morris. A review of PTSD treatment programs of the US Veterans Administration. Report for the Department of Veterans? Affairs, Canberra, 1994.
PLP Morris. Progress Report, National Centre for War Related Post-Traumatic Stress Disorder. Department of Veterans? Affairs, Canberra, 1994.
PLP Morris. A review of the efficacy of Venlafaxine for major depression. Therapeutic Goods Administration, Canberra, 1995.
PLP Morris. Progress Report, National Centre for War Related Post-Traumatic Stress Disorder. Department of Veterans? Affairs, Canberra, 1995.
PLP Morris. Progress Report, National Centre for War Related Post-Traumatic Stress Disorder. Department of Veterans? Affairs, Canberra, 1996.
PLP Morris. A review of the efficacy of Paroxetine for PTSD. Therapeutic Goods Administration, Canberra, 2001.
PLP Morris. A review of the efficacy of Clozapine for suicidality in schizophrenia and schizoaffective disorder. Therapeutic Goods Administration, Canberra, 2003.
PLP Morris. A review of the efficacy of Suboxone for opiate addiction. Therapeutic Goods Administration, Canberra, 2004.
PLP Morris. A review of the efficacy of Ziprasidone for bipolar mania. Therapeutic Goods Administration, Canberra, 2006.
PLP Morris. A review of the efficacy of Memantine for treatment of severe Alzheimer?s disease. Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee, Canberra, 2008.
PLP Morris. A review of the pharmacotherapy for post traumatic stress disorder. Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee, Canberra, 2009.
PLP Morris. A review of Donepezil and Memantine in the treatment of PTSD. Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee, Canberra, 2009.
PLP Morris. A selected review of the management of insomnia. Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee, Canberra, 2009.
PLP Morris. Prazosin for the treatment of traumatic nightmares in veterans suffering from PTSD. Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee, Canberra, 2010.
PLP Morris. New melatonin-based hypnotic and antidepressant medications. Department of Veterans? Affairs Repatriation Pharmaceutical Reference Committee, Canberra, 2010.
Dunt D, Doyle C, MacFarlane AC, Morris PLP, Hunter C, Day S. The Impact of War Experiences on Dementia in Veterans: Report. Centre for Health Policy Programs & Economics, The University of Melbourne, Melbourne, June 2011.
Dunt D, Doyle C, MacFarlane A, Morris PLP, Hunter C, Day S. The impact of war experiences on dementia in veterans: final report, March 2012. Centre for Health Policy Programs & Economics, The University of Melbourne, Melbourne, March 2012.
Newsletters Published as Editor
Pacific Rim College of Psychiatrists, Newsletter, May 2002.
Pacific Rim College of Psychiatrists, Newsletter, September 2002.
Pacific Rim College of Psychiatrists, Newsletter, December 2002.
Pacific Rim College of Psychiatrists, Newsletter, April 2003.
Pacific Rim College of Psychiatrists, Newsletter, August 2003.
Pacific Rim College of Psychiatrists, Newsletter, November 2003.
Pacific Rim College of Psychiatrists, Newsletter, March 2004.
Pacific Rim College of Psychiatrists, Newsletter, August 2004.
Pacific Rim College of Psychiatrists, Newsletter, December 2004.
Pacific Rim College of Psychiatrists, Newsletter, January 2005.
Pacific Rim College of Psychiatrists, Newsletter, June 2005.
Pacific Rim College of Psychiatrists, Newsletter, November 2005.
Pacific Rim College of Psychiatrists, Newsletter, March 2006.
Pacific Rim College of Psychiatrists, Newsletter, August 2006.
Pacific Rim College of Psychiatrists, Newsletter, December 2006.
Medical Society Membership
Australian Medical Association, 1975 ? current.
American Medical Association, 1988-1993.
Hunter Medical Association, NSW, Australia, 1983-87.
Assistant Secretary, 1983.
Secretary, 1984-85.
Newcastle Medico-Legal Association, NSW, Australia, 1983-87.
Foundation Secretary, 1983-87.
Foundation President, Association of Psychiatrists-in-Training, NSW, 1980-81.
RANZCP (NSW Branch), 1983-92.
Assistant Secretary, 1983.
Secretary, 1984-85.
RANZCP (Victorian Branch), 1992 ? 1997.
RANZCP (Queensland Branch), 1997 ? current.
Australian Society for Psychiatric Research, 1983 ? current.
Transplant Society of Australian and New Zealand, 1986-89.
Foundation Member, Australian Society of Biological Psychiatry, 1986 ? current.
Distinguished Fellow, Pacific Rim College of Psychiatrists, 2001 ? current.
Board Director, Pacific Rim College of Psychiatrists, 2006 ? 2010.
Vice President, Pacific Rim College of Psychiatrists, 2008 ? 2010.
President, Gold Coast Medical Association, 2007 ? 2009.
Councilor, Australian Medical Association Queensland Branch, 2010.
Community Associations
Newcastle Rotary Club, NSW, Australia, Member, 1985-87.
Chairman, International Service Committee, Newcastle Rotary Club,
1986-87.
Honors and Awards
The University of NSW: Alumni Award for Achievement (Service to the Australian and Asia-Pacific Student Community in the Field of Medical Education), 1975.
Rotary Foundation (Rotary International): Group Study Exchange Scholarship (to visit Rotary District 789, Connecticut and Massachusetts, USA), 1984.
Source: http://www.drphilipmorris.com/current-curriculum-vitae-philip-morris/
devils dodgers rachel maddow gia la riots new jersey devils torn acl
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন